The DOI matches its Crossref record; the references it cites are not checked yet.
The Benefit of Short-Term Weight Loss with Anti-Obesity Medications in Real-World Clinical Practice
Abstract
Objective: The effectiveness of anti-obesity medications (AOMs) outside of clinical trials is unclear. The objective of this study was to compare the short-term effectiveness of AOMs in real-world practice. Methods: This retrospective study included adults aged ≥18 years, with body mass index ≥30 kg/m 2 or ≥27 kg/m 2 with at least one obesity-related comorbidity who were prescribed phentermine hydrochloride, phenterminetopiramate, bupropion-naltrexone, or lorcaserin for 12 consecutive weeks between 2006 and 2016 at a large tertiary healthcare system. Propensity score-matched cohorts were created for each pair of AOMs. The primary outcomes were percent and absolute weight loss from baseline after 12 weeks. A prediction model was constructed to estimate weight loss with different AOMs based on demographic and clinical data. Results: Of the 3,411 patients included in this study, patients lost an average of 3.45% of body weight from baseline. All AOMs were associated with a significant weight loss from baseline ( P Conclusion: In real-world practice, AOMs are associated with clinically meaningful weight loss of 2 to 4% after 12 weeks. In this study, phentermine hydrochloride and phentermine topiramate produced the most weight loss. AOMs should be seriously considered as part of the armamentarium to treat patients with obesity. Abbreviations: AOM = anti-obesity medication; BMI = body mass index; EMR = electronic medical record; FDA = Food and Drug Administration; T2D = type 2 diab…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
The citation lists are queued
They are fetched later and appear here then.
References 22 · Cited by 27
Metadata
- Authors
- Shibuya, K., Ali, K. F., Ji, X., Milinoivh, A., Bauman, J., Kattan, M. W., Pantalone, K. M., & Burguera, B.
- Affiliations
- Cleveland Clinic Lerner College of Medicine (US)
- Cleveland Clinic (US)
- Corresponding author
- Burguera, Bartolome
- Venue
- Endocrine Practice
- Publisher
- Elsevier BV
- Published
- 2019-10
- Volume
- 25
- Issue
- 10
- Pages
- 1022-1028
- ISSN
- 1530-891X (ISSN-L)
- OpenAlex
- W2953705715
- Cited by
- 27
- References
- 22
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 3 · 2023: 2 · 2022: 4 · 2021: 4 · 2020: 10
- FWCI
- 2.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Endocrine Practice (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Keywords
- anti-obesity drugs, short-term weight loss, phentermine/topiramate, naltrexone/bupropion, lorcaserin, obesity, obesity-related comorbidities, real-world effectiveness, propensity score matching
- MeSH terms
- Topiramate, Adult, Diabetes Mellitus, Type 2, Fructose, Humans, Obesity, Retrospective Studies, Weight Loss, Anti-Obesity Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Benefit of Short-Term Weight Loss with Anti-Obesity Medications in Real-World Clinical Practice. https://app.cochat.ai/papers/10.4158/ep-2019-0081
- The paper
- Shibuya, K., Ali, K. F., Ji, X., Milinoivh, A., Bauman, J., Kattan, M. W., Pantalone, K. M., & Burguera, B. (2019). The Benefit of Short-Term Weight Loss with Anti-Obesity Medications in Real-World Clinical Practice. Endocrine Practice. https://doi.org/10.4158/ep-2019-0081
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.